切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - MET - 5-Lipoxygenases - Angiotensin-Converting Enzymes (ACEs) - Urokinases

13件产品中的 1-10

页面
每页
清除全部
  1. Amiloride HCl dihydrate
    B2268 Amiloride HCl dihydrate
    中文名: 盐酸阿米洛利二水合物
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Urokinases
    Summary: 有效上皮钠通道(ENaC)阻断剂
      ≥14.05 mg/mL
      insoluble in H2O
  2. BMS-794833
    B1438 BMS-794833
    Target: MET|Flk-1
    Summary: Met/VEGFR2抑制剂
      ≥23.45 mg/mL
      insoluble in H2O
  3. Perindopril
    B1214 Perindopril
    中文名: 培哚普利
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE抑制剂
      Soluble in DMSO
  4. Benazepril HCl
    B2216 Benazepril HCl
    中文名: 盐酸贝那普利
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: 血管紧张素转换酶(ACE)抑制剂
      ≥18.2 mg/mL
      ≥18.1 mg/mL
  5. MK-2461
    A8476 MK-2461
    Target: FLT3|PDGFR|MET|Ron
    Summary: C-Met(野生型/突变型)抑制剂
      ≥24.8 mg/mL
      insoluble in H2O
  6. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met抑制剂
      ≥18.47 mg/mL
      ≥2.29 mg/mL
  7. Butein
    A2689 Butein
    中文名: 紫铆因,紫铆查尔酮
    Target: Src|STAT|EGFR|Angiotensin-Converting Enzymes (ACEs)|5-Lipoxygenases|PTK|enoyl-acyl-carrier protein reductase
    Summary: 蛋白激酶抑制剂
      ≥13.6 mg/mL
      insoluble in H2O
  8. BMS-777607
    A5703 BMS-777607
    Target: MET
    Summary: 强效的c-Met选择性抑制剂
      ≥25.65 mg/mL
      insoluble in H2O
  9. Perindopril Erbumine
    A8019 Perindopril Erbumine
    中文名: 培哚普利叔丁胺盐
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE抑制剂
      ≥8.58 mg/mL
      ≥111.4 mg/mL
  10. SGX-523
    A1196 SGX-523
     1 Citation
    Target: MET
    Summary: 高度选择性的、ATP竞争性的Met抑制剂
      ≥17.95 mg/mL

13件产品中的 1-10

页面
每页